As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Capital Product Partners

  • Tuesday's Range: $6.76-$7.14
  • 52-Week Range: $5.56-$10.06
  • Tuesdays Volume: 578,000
  • Three-Month Average Volume: 373,335

Capital Product Partners(CPLP) - Get Report , a shipping company, provides marine transportation services in Greece. This stock traded up 5.8% to $7.09 in Tuesday's trading session.

From a technical perspective, Capital Product Partners ripped sharply higher on Tuesday right off both its 20-day moving average of $6.75 and its 50-day moving average of $6.80 with above-average volume. This high-volume move to the upside also pushed shares of Capital Product Partners into breakout territory, since the stock cleared some near-term overhead resistance at $7.08 a share. Market players should now look for a continuation move to the upside in the short-term if this stock manages to take out Tuesday's intraday high of $7.14 with strong volume.

Traders should now look for long-biased trades in Capital Product Partners as long as it's trending above its 20-day moving average of $6.75 and then once it sustains a move or close above Tuesday's high of $7.14 with volume that hits near or above 373,335 shares. If that move gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $7.40 to $7.50, or even its 200-day moving average of $7.98 to $8.20 a share.

Prima Biomed

  • Tuesday's Range: $1.21-$1.27
  • 52-Week Range: $0.42-$6.48
  • Tuesday's Volume: 599,000
  • Three-Month Average Volume: 1.27 million

Prima Biomed (PBMD)  researches, develops and commercializes medical biotechnology products in Australia. This stock traded up 1.6% to $1.23 in Tuesday's trading session.

From a technical perspective, Prima Biomed trended modestly higher on Tuesday right off both its 20-day moving average of $1.21 and its 50-day moving average of $1.22 a share with lighter-than-average volume. This stock has been attempting to carve out a major bottoming chart pattern over the last two months, with shares finding buying interest at around $1.15 to $1.12 a share. Shares of Prima Biomed are now starting to spike higher off those support levels and it's quickly moving within range of triggering a big breakout trade above some key near-term overhead resistance levels. That breakout will trigger if this stock manages to take out some near-term overhead resistance levels at $1.36 to $1.41 and then above more resistance at $1.48 with high volume.

Traders should now look for long-biased trades in Prima Biomed as long as it's trending above its 20-day at $1.21 or its 200-day at $1.16 and then once it sustains a move or close above $3 a share with volume that hits near or above 1.27 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.73 to $1.80, or even $2 a share.

Sorrento Therapeutics

  • Tuesday's Range: $7.69-$8.01
  • 52-Week Range: $3.70-$26.80
  • Tuesday's Volume: 513,000
  • Three-Month Average Volume: 551,005

Sorrento Therapeutics(SRNE) - Get Report , a biopharmaceutical company, focuses on the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the U.S., Europe and internationally. This stock traded up 1% to $7.90 in Tuesday's trading session.

From a technical perspective, Sorrento Therapeutics trended modestly higher on Tuesday right above its recent low of $7.25 with decent upside volume flows. This move to the upside on Tuesday is now quickly pushing shares of Sorrento Therapeutics within range of triggering a major breakout trade above some key near-term overhead resistance levels. That breakout will trigger if this stock manages to take out some near-term overhead resistance levels at $8.21 to its 20-day moving average of $8.29 a share with high volume.

Traders should now look for long-biased trades in Sorrento Therapeutics as long as it's trending above Tuesday's intraday low of $7.69 or above its recent low of $7.25 and then once it sustains a move or close above those breakout levels with volume that hits near or above 551,005 shares. If that breakout gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.19 to its 50-day moving average of $10.71 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.